| Name | Title | Contact Details |
|---|
What`s best for each patient drives our business. Through Center for Diagnostic Imaging`s national network, including Insight Imaging, we partner with healthcare providers to do what we do best — manage and deliver high-quality medical imaging (i.e. MRI, PET/CT, etc.) and related services (i.e. injections for pain) to enhance patient care. CDI offers the highest quality of care through a network of outpatient imaging centers and mobile facilities in more than thirty states. Headquartered in Minneapolis, Minnesota; the organization serves more than one million patients a year through a diverse set of customers including healthcare providers, managed care organizations, hospitals, health systems and payors (government and third party). Our local providers and partners are connected through CDI`s large network to other clinical providers and staff across the country. Through CDI`s sophisticated network, our partners access best practices and have the ability to consult with other specialized physicians, when needed, to improve patient care and outcomes. Being a national provider that is locally focused helps CDI provide each patient with the best of both worlds: individualized local patient care and extensive healthcare expertise.
Roush Life Sciences is a Salem, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.
UMC Inc. is a Aurora, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Physio-Control, now part of Stryker, is the world leader in the development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. We envision a world in which no person dies suddenly as a result of an acute, treatable medical event. Physio-Control Team Members are part of a unique group who love what they do - and why they do it. Our Team is comprised of talented individuals who have purpose, creativity and passion, and we are proud to be leading the industry dedicated to saving and extending lives around the globe. Our Team Members are our most valuable asset and what sets us apart from our competitors. We are committed to our mission to save lives through hard work and dedication.